Candid Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Candid Therapeutics's estimated annual revenue is currently $6.7M per year.
- Candid Therapeutics's estimated revenue per employee is $155,000
- Candid Therapeutics's total funding is $445M.
Employee Data
- Candid Therapeutics has 43 Employees.
Candid Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO, Chairman the Board | Reveal Email/Phone |
2 | Chairman, President and CEO | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Chief Medical Officer and Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Medical Officer & Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Financial Officer & Chief Business Officer | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | SVP Regulatory and Quality | Reveal Email/Phone |
9 | SVP, Portfolio and Program Management | Reveal Email/Phone |
10 | VP Clinical Science | Reveal Email/Phone |
Candid Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Candid Therapeutics?
Clinical stage biotechnology company dedicated to advancing the treatment of a range of immunological conditions
keywords:N/A$445M
Total Funding
43
Number of Employees
$6.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.4M | 43 | 0% | N/A |
#2 | $7.8M | 43 | 30% | N/A |
#3 | $5M | 43 | 0% | N/A |
#4 | $8.4M | 43 | N/A | N/A |
#5 | $7.1M | 43 | 2% | N/A |